Floatz logo

Immunoglobulin G1, anti-(human/Macaca fascicularis/Macaca mulatta killer cell lectin-like receptor KLRD1) (human monoclonal DR-01 ?1-chain), disulfide with human monoclonal DR-01 ?-chain, dimer

Hepatosplenic T-cell Lymphoma

Dren Biomonoclonal_antibodyPhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Hepatosplenic T-cell Lymphoma cohort.

Asset / SponsorPhaseRating
Fludarabine
National Cancer Institute (NCI)
Phase 2BBB
ETOPOSIDE
City of Hope Medical Center
Phase 4BBB
Inno-206
National Cancer Institute (NCI)
Phase 4BBB
Ifosfamide
Shandong Provincial Hospital
Phase 4BBB
Inno-206
National Cancer Institute (NCI)
Phase 4BBB

View all 50 →

Same molecule, other indications

Immunoglobulin G1, anti-(human/Macaca fascicularis/Macaca mulatta killer cell lectin-like receptor KLRD1) (human monoclonal DR-01 ?1-chain), disulfide with human monoclonal DR-01 ?-chain, dimer is also rated in:

primary cutaneous gamma-delta t-cell lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
primary cutaneous aggressive epidermotropic CD8+ T-cell lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
T-cell large granular lymphocyte leukemiaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →